Is Gardiner Healthcare Acquisitions Corp. overvalued or undervalued?

Jun 25 2025 09:34 AM IST
share
Share Via
As of October 1, 2023, Gardiner Healthcare Acquisitions Corp. is considered attractive due to its undervaluation, with a P/E ratio of 15.2, a P/B ratio of 1.1, and a 12% ROE, outperforming peers like Acacia Research Corp. and HCA Healthcare, Inc. in market sentiment.
As of 1 October 2023, Gardiner Healthcare Acquisitions Corp. has moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.1, and a Return on Equity (ROE) of 12%.

In comparison to its peers, such as Acacia Research Corp. with a P/E of 18.5 and HCA Healthcare, Inc. with a P/E of 14.7, Gardiner appears to be trading at a discount. This valuation is further supported by the company's recent stock performance, which has outpaced the Sensex, indicating positive market sentiment despite broader market trends.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News